Impediments to successful immunotherapy (Q33586651)

28 July 2017

1 reference

title

Impediments to successful immunotherapy (English)

1 reference

28 July 2017

1 reference

Hersey P

1

1 reference

28 July 2017

publication date

1 February 1999

1 reference

Pharmacology & Therapeutics

28 July 2017

published in

1 reference

28 July 2017

volume

81

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

111-119

1 reference

A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Contributions of basic immunology to human health

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Remission maintenance therapy with histamine and interleukin-2 in acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Altered immune responses in interleukin 10 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Histamine in immunotherapy of advanced melanoma: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Histamine in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

The melanotropic peptide, [Nle4,D-Phe7] alpha-MSH, stimulates human melanoma tyrosinase activity and inhibits cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Melanotropic peptide receptors: membrane markers of human melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Immunohistochemical evidence of alpha-, beta- and gamma 3-melanocyte stimulating hormone expression in cutaneous malignant melanoma of nodular type

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Characterisation of human malignant melanoma cell lines. VI. Inhibition of 3H-thymidine uptake by normal stimulated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

In situ expression of transforming growth factor ?? is associated with melanoma progression and correlates with Ki67, HLA-DR and ?? 3 integrin expression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Contrasting effects of T cell growth factors on T cell responses to melanoma in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Mechanisms responsible for signaling and functional defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Selective expression of an interleukin-12 receptor component by human T helper 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Modulation of T-cell function by gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

1 reference

7 January 2021

Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Immunosuppressive activity of the retroviral envelope protein P 15E and its possible relationship to neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

CD4 T cells kill melanoma cells by mechanisms that are independent of Fas (CD95).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

IL-6 and APPs: anti-inflammatory and immunosuppressive mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900038-2

7 January 2021

10.1016/S0163-7258(98)00038-2

Identifiers

DOI

1 reference

28 July 2017

1 reference